Tower Research Capital LLC (Trc) Capricor Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 23,824 shares of CAPR stock, worth $314,238. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,824
Previous 9,524
150.15%
Holding current value
$314,238
Previous $45,000
704.44%
% of portfolio
0.01%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CAPR
# of Institutions
93Shares Held
8.13MCall Options Held
1.78MPut Options Held
1.4M-
Black Rock Inc. New York, NY1.63MShares$21.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$20.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA638KShares$8.42 Million0.0% of portfolio
-
State Street Corp Boston, MA512KShares$6.76 Million0.0% of portfolio
-
Superstring Capital Management LP New York, NY337KShares$4.45 Million4.49% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $321M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...